🔴 MDxHealth is trading 7.37% down in pre-market — with no clear company-specific catalyst

MDxHealth is trading 7.37% down at $0.54 in pre-market; no clear company-specific catalyst was found for October 1.

• It gained 12.42% to $0.58 at the September 30 close.
• Its 2026 press-release archive lists second-quarter results on August 13 as the latest release; no October 1 announcement is shown.
• Broader pre-market signals are mixed, and available evidence does not establish a market-wide explanation.